about
Some vexations that challenge viral immunologyIn Hot Pursuit of the First Vaccine Against Respiratory Syncytial VirusDeterminants of early life immune responses to RSV infectionApproved Antiviral Drugs over the Past 50 YearsA Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSVVaccines against respiratory syncytial virus: The time has finally come.Antibody response to respiratory syncytial virus infection in children <18 months oldIterative structure-based improvement of a fusion-glycoprotein vaccine against RSV.Respiratory syncytial virus infection: an innate perspective.A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant.Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection.Immunopathogenesis associated with formaldehyde-inactivated RSV vaccine in preclinical and clinical studies.Respiratory Syncytial Virus Infection: An Illness for All Ages.Passive and active immunization against respiratory syncytial virus for the young and old.Neutralizing epitopes of RSV and palivizumab resistance in Japan.Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation.Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.Influence of antigen conformation and mode of presentation on the antibody and protective responses against human respiratory syncytial virus: relevance for vaccine development.Targeting Host Cell Surface Nucleolin for RSV Therapy: Challenges and Opportunities.An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection.Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus.The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron TomographyRemoval of the N-Glycosylation Sequon at Position N116 Located in p27 of the Respiratory Syncytial Virus Fusion Protein Elicits Enhanced Antibody Responses after DNA Immunization
P2860
Q24672537-0C49E9AB-56CB-4164-94B1-FA7FD387F7B9Q26748856-394CCBA1-BA75-4A40-B927-3A9C1BBAE4EDQ26764790-BCF3551E-D8BE-4821-AF8B-A29DD4B64067Q27755387-509369B2-C5A7-45F2-8395-1121C577BDBAQ36029158-25DB96A0-3ADC-4DEB-9A46-BECD15C65B88Q37018347-F4AA522F-75E9-47CF-A562-959A8B1270D1Q37135395-0352B6EA-AE21-46A4-8726-EC6DEE77FB13Q37242530-6D46F353-832B-45B4-94C4-ED6B804C32D6Q37577700-5BC1F650-4A66-44A8-9A47-E3BB8D1B222AQ37578458-940C86E7-1BCC-4D6A-8741-D7F67BE5349FQ38694691-28CB4962-DB3C-4ED7-B2DE-1F9DC2A5EA0AQ39007664-F176EF0F-9102-4DE9-9C93-1E8451D74787Q39118423-7746BDAB-51C7-4644-9D35-F618FF290359Q39318498-206F0188-7CA6-4C3C-B1BD-50BF80DE2772Q40059727-8ACC7A9D-55AB-441E-B3D4-45C20CFE0601Q40216566-CDD3F893-563B-40B5-8E41-78EF01547950Q40244825-FC7DB0FF-F9D8-40EE-8206-67ED92942304Q40301155-100C3C8D-2D75-44E0-BDC6-C951EFBE5147Q40812866-7BDC1662-DC4A-4469-A440-63B5FA119492Q41813514-D51900C9-C63F-47BF-A594-9AF0AE328B21Q45326384-6D4131C7-656A-4A0F-8132-F368CDD5C03FQ47238680-A6555506-D3D8-4097-A71B-19716E19748FQ54209804-6CCB792D-3F28-4F16-B3E0-1F567D95CBFAQ56972195-4865BA0E-1C6F-4097-A2EA-3295214F93E9Q58780345-783F4F5E-C7EC-477B-A87C-14B3F41D721D
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Novel antigens for RSV vaccines.
@ast
Novel antigens for RSV vaccines.
@en
type
label
Novel antigens for RSV vaccines.
@ast
Novel antigens for RSV vaccines.
@en
prefLabel
Novel antigens for RSV vaccines.
@ast
Novel antigens for RSV vaccines.
@en
P2860
P1476
Novel antigens for RSV vaccines.
@en
P2093
Jason S McLellan
P2860
P356
10.1016/J.COI.2015.04.005
P577
2015-06-09T00:00:00Z